| Authors | Maria Gavriatopoulou, Efstathios Kastritis, Marie-Christine Kyrtsonis, Theodoros P Vassilakopoulos, Maria Roussou, Despoina Fotiou, Magdalini Migkou, Maria Mpakiri, Anna Tasidou, Evangelos Terpos, Meletios Athanasios Dimopoulos |
| Journal | Leukemia & lymphoma
(Leuk Lymphoma)
Vol. 58
Issue 6
Pg. 1506-1508
(06 2017)
ISSN: 1029-2403 [Electronic] United States |
| PMID | 27724158
(Publication Type: Clinical Trial, Phase II, Letter)
|
| Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Cyclophosphamide
- Vidarabine
- ofatumumab
- fludarabine
|
| Topics |
- Antibodies, Monoclonal
(administration & dosage)
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Cyclophosphamide
(administration & dosage)
- Drug Resistance, Neoplasm
- Humans
- Recurrence
- Retreatment
- Survival Analysis
- Treatment Outcome
- Vidarabine
(administration & dosage, analogs & derivatives)
- Waldenstrom Macroglobulinemia
(drug therapy, mortality, pathology)
|
